🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial examines the use of blood-based biomarkers is to help i...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-02-21
Trial ID
NCT05541016
Treatments Being Tested
Blood flow restriction (BFR) therapy is a brief and partial restriction of ...
Status
Recruiting
Location
NYU Langone Health
Start Date
2021-10-08
Trial ID
NCT04104126
Treatments Being Tested
As in this modern era of digitalization; mobile phones, touch pads and comp...
Status
Completed
Location
Riphah International University
Start Date
2024-01-12
Trial ID
NCT06866821
Treatments Being Tested
In advanced metastatic castration resistant prostate cancer (mCRPC) progres...
Status
Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2024-08-01
Trial ID
NCT06216249
This clinical trial studies how well intensity modulated proton therapy (IM...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2022-02-16
Trial ID
NCT05075980
The purpose of this study was to evaluate the efficacy of a one-time, preop...
Status
Completed
Location
Multiple Locations
Start Date
2015-02
Trial ID
NCT02872337
This phase III trial studies whether adding apalutamide to the usual treatm...
Status
Active Not Recruiting
Location
Cancer Center at Saint Joseph's
Start Date
2020-04-16
Trial ID
NCT04134260
This phase II trial compares the impact of brentuximab vedotin and nivoluma...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-04
Trial ID
NCT07572123
Treatments Being Tested
The main aim of this study is to verify the influence of placebo on the eff...
Status
Unknown
Location
Mercè Balasch i Bernat
Start Date
2020-10-16
Trial ID
NCT04640337
Currently, the first-line combination of artemisinin, piperaquine and prima...
Status
Completed
Location
Kori Puskesmas
Start Date
2022-11-01
Trial ID
NCT05829187
Treatments Being Tested